To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05634499
Title A Study of Giredestrant in Participants With Grade 1 Endometrial Cancer (EndomERA)
Acronym EndomERA
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | POL | ITA | CAN

Facility Status City State Zip Country Details
University of Arkansas for Medical Sciences Little Rock Arkansas 72205 United States Details
Mount Sinai Medical Center Miami Beach Florida 33140 United States Details
Minnesota Oncology Minneapolis Minneapolis Minnesota 55404 United States Details
Englewood Health/Hematology Oncology Practice of Englewood (HOPE) Englewood New Jersey 07631 United States Details
Western Pennsylvania Hospital Pittsburgh Pennsylvania 15224 United States Details
Texas Oncology, P.A. - Fort Worth Fort Worth Texas 76104 United States Details
Virginia Oncology Associates Norfolk Virginia 23502 United States Details
Jewish General Hospital Montreal Quebec H3T 1E2 Canada Details
McGill University Health Centre - Glen Site Montreal Quebec H4A 3J1 Canada Details
Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori IRST - PPDS Meldola Emilia-Romagna 47014 Italy Details
Narodowy Inst.Onkol.im.Sklodowskiej-Curie Panstw.Inst.Bad Gliwice Gliwice 44-101 Poland Details
Swietokrzyskie Centrum Onkologii Kielce 25-734 Poland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field